Treatment | T1 (%) | T2 (%) | T3 (%) | T4 (%) |
|---|
C | 92.33 ± 1.20 | 10.33 ± 0.89 | 0 | 0 |
CAP | 94.32 ± 1.02 | 5.66 ± 1.12 | 0 | 0 |
10c | 49.67 ± 0.88*
| 38.32 ± 1.43*
| 12.01 ± 0.57*
| 0 |
(inv)10c | 92.65 ± 0.86 | 7.36 ± 0.78 | 0 | 0 |
11e | 91.67 ± 1.48 | 8.39 ± 0.90 | 0 | 0 |
AP | 37.69 ± 2.35*
| 55.63 ± 3.06*
| 5.00 ± 0.53*
| 1.62 ± 0.23*
|
- The data are presented as the mean ± SEM. Types of degeneration tubular in each treatment [CAP, 10c, inv(10c), 11e and AP] were compared to the control (C), and significant differences as assessed through one-way ANOVA followed by the Tukey test as a post hoc test (* p < 0.05). Normal tubules (T1); hypospermatogenic tubules (T2); arrested maturation tubules (T3); tubules containing spermatogonia and Sertoli cells or Sertoli-cell-only tubules (T4). C, control; CAP, captopril; (inv)10c, containing the inverted BPP-10c sequence; 10c, BPP-10c; 11e, BPP-11e; AP, BPP-AP
